1. Home
  2. OGEN vs BREA Comparison

OGEN vs BREA Comparison

Compare OGEN & BREA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OGEN
  • BREA
  • Stock Information
  • Founded
  • OGEN 1996
  • BREA 2022
  • Country
  • OGEN United States
  • BREA Ireland
  • Employees
  • OGEN N/A
  • BREA N/A
  • Industry
  • OGEN Biotechnology: Pharmaceutical Preparations
  • BREA Services-Misc. Amusement & Recreation
  • Sector
  • OGEN Health Care
  • BREA Consumer Discretionary
  • Exchange
  • OGEN Nasdaq
  • BREA Nasdaq
  • Market Cap
  • OGEN 9.8M
  • BREA 9.9M
  • IPO Year
  • OGEN N/A
  • BREA 2023
  • Fundamental
  • Price
  • OGEN $1.02
  • BREA $0.72
  • Analyst Decision
  • OGEN
  • BREA
  • Analyst Count
  • OGEN 0
  • BREA 0
  • Target Price
  • OGEN N/A
  • BREA N/A
  • AVG Volume (30 Days)
  • OGEN 135.2K
  • BREA 16.9K
  • Earning Date
  • OGEN 08-12-2024
  • BREA 07-23-2024
  • Dividend Yield
  • OGEN N/A
  • BREA N/A
  • EPS Growth
  • OGEN N/A
  • BREA N/A
  • EPS
  • OGEN N/A
  • BREA N/A
  • Revenue
  • OGEN $20,629.00
  • BREA $120,788.00
  • Revenue This Year
  • OGEN N/A
  • BREA N/A
  • Revenue Next Year
  • OGEN N/A
  • BREA N/A
  • P/E Ratio
  • OGEN N/A
  • BREA N/A
  • Revenue Growth
  • OGEN N/A
  • BREA N/A
  • 52 Week Low
  • OGEN $0.97
  • BREA $0.53
  • 52 Week High
  • OGEN $7.74
  • BREA $3.00
  • Technical
  • Relative Strength Index (RSI)
  • OGEN 35.56
  • BREA 37.60
  • Support Level
  • OGEN $1.00
  • BREA $0.67
  • Resistance Level
  • OGEN $1.19
  • BREA $0.74
  • Average True Range (ATR)
  • OGEN 0.07
  • BREA 0.06
  • MACD
  • OGEN 0.02
  • BREA 0.01
  • Stochastic Oscillator
  • OGEN 6.25
  • BREA 41.29

About OGEN Oragenics Inc.

Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's lead product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification.

About BREA Brera Holdings PLC

Brera Holdings PLC focused on expanding social impact football by developing a global portfolio of emerging football clubs with increased opportunities to earn tournament prizes, gain sponsorships, and provide other professional football and related consulting services.

Share on Social Networks: